Live Placebo updates

Live Placebo news coverage of developments with the latest updates. Stay on top of latest Placebo news stories and find out what just happened, what is going on with Placebo. The latest real-time news updates and headlines on Placebo
CHMP Backs Klygefa for EU Approval in Treating gMG
Efzimfotase Alfa Gets US Priority Review for HPP Treatment
Teaching Immune System To Control HIV
New Method Eases IUD Insertion Pain for Women
Mepivacaine vs. Placebo: IUD Pain Study Results
Researchers Aim to Improve Psychedelic Trials
Compounding Problem Of Peptides
Research: Drug Boosts Sexual Function in Depressed Patients
Canadian First: Volunteers Exposed To Flu For Research
Azithromycin Use Rises, Infections Drop Post C-Section Trial
Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer
Eight-Year ADAURA Update: Osimertinib Boosts Survival
Atezolizumab Combo Doubles Event-Free Survival in NSCLC
Loberamisal Targets Acute Ischemic Stroke
Can Ketones Help Us Age Better?
Bacterial Trial Fails to Show Early Asthma Prevention
New Therapy Cuts COPD Flare-Ups, Trials Show
Tozorakimab Reduces COPD Exacerbations in Phase III Trials
Science-Backed Workout Recovery vs
UCLA Expert on New Treatment for Short-limb Dwarfism
New Biomarkers Show Dystrophy Drug May Stunt Growth
Ketamine, Therapy Combo Promising for Chronic Pain
UCSF Cancer Vaccine Trial Heralds New Treatment Era
Hormone Therapy May Ease Menopause Brain Fog
Tagrisso, Orpathys Boost PFS in EGFR Lung Cancer
Research Shows Extended PAXLOVID No Help for Long COVID
Cholesterol Drug Cuts Heart Attack, Stroke Risk 30%
Plozasiran Slashes Triglyceride Levels in Hypertriglyceridemia
Catheter Ablation Fails to Boost Atrial Fibrillation QoL
Metformin Fails to Protect Against Heart Failure Outcomes
New Drug Shows Promise in Early Heart Failure Trial
Heart Failure Drug Combo Shows No Benefit
Milvexian Fails to Cut Cardiovascular Events in Trial
Monoclonal Antibody Cuts Inflammation for Six Months
Novel Antibody Drug Cuts Inflammatory Markers
Cholesterol Drug Cuts Heart Events 30% in Older Adults
Trial Explores New Treatment for Inherited Heart Disease
Aficamten Trial Shows Promise for Heart Condition
Eplontersen Trial Misses Key Goal in Amyloid Cardiomyopathy
20 Years, Millions Saved: Revolutionary Vaccine
Patients Miss Out on Heart Benefits of BP-Lowering Meds
Promising Results in Early Common Cold Vaccine Trials
Tezspire Shows Positive Phase III Results in EoE Study
Paris Jackson's ECT for Depression: Controversy Lingers
Diabetes Drug Cuts Preterm Births in High-Risk Cases
Ethnopharmacology Vs. Emerging Diseases: Nigeria's Lessons
Rare Airway Disease Took Her Breath Away
Peppermint Oil Cuts Blood Pressure in 20 Days